Delivery Order SPE2DB22D2005-SPE2DB25FJPE8
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,963.54 firm fixed-price delivery order is for the supply of the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is a delivery order for the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine product. The contract is a firm fixed-price arrangement with a performance period extending through May 7, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is for the procurement of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
- This is a $1,963.54 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has a period of performance through February 18, 2025 and was awarded on January 27, 2025. There is no set-aside designation for this contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, with a ceiling value of $1,856.75 and a period of performance through May 21, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $167,107.50 firm-fixed-price contract, with a performance period through July 2024, is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,477.36, is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The award is placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a...
- This federal contract award, valued at $1,963.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, with a completion date of May 13, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $1,958.00 and a period of performance through July 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The award has a ceiling value of $4,204.99 and a completion date of May 8, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJPE8Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has a ceiling value of $1,963.54 and is a firm fixed price, delivery order contract. The contract is not set aside and has an ultimate completion date of July 22, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, allowing the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/30/25 |